Apimeds Pharmaceuticals US Statistics
NYSE: APUSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.60-0.14 (-8.05%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Apimeds Pharmaceuticals US by the numbers
Apimeds Pharmaceuticals US has a market capitalization of $3.0 million based on 1.85M shares outstanding. With trailing EPS of $-12.69, Apimeds Pharmaceuticals US is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 52.9% below its 50-day average and 83.6% below its 200-day average.
Average daily trading volume is 3.73M shares, or about $6.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
APUS valuation vs. peer median
| Metric | APUS | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.96M | $3.12M | -5% |
| Avg. volume | 3.73M | 363.29K | +926% |
Peer median across 8 companies: JAGX, SKYE, GELS, AZTR, MDCX, KPRX, NRSN, TRAW.
Valuation
- Market cap
- $2.96M
- EPS (TTM)
- $-12.69
- Shares outstanding
- 1.85M
Price and trading
- Previous close
- 1.74
- Open
- 1.77
- Day range
- 1.51 – 1.77
- 52-week range
- 1.51 – 59.70
- 52-week change
- -92.98%
- Beta
- —
- Volume
- 48.55K
- Average volume
- 3.73M
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 2.96M
- Eps
- -12.69
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 59.70
- Week52 Low
- 1.51
- Avg Volume
- 3.73M
- Shares Outstanding
- 1.85M
- Ma50
- 3.39
- Ma200
- 9.73
- Pct From52w High
- -97.32%
- Pct From52w Low
- 5.96%